Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors — Vincenzo Nasca (2025) | RDL Network
Sex and outcomes of patients with microsatellite instability-high and <i>BRAF</i> V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
Article 2025 en
Authors
VN
Vincenzo Nasca
JZ
Joseph J. Zhao
JR
Javier Ros
Abstract
1 min read
Overall, our findings suggest a complex interplay between sex and <i>BRAF</i> mutational status that may modulate the activity of ICIs in patients with MSI-H mCRC and pave the way to novel tailored strategies.
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
João M. Alves, Nuria Estévez‐Gómez, Roberto Piñeiro, Laura Muinelo‐Romay, Patricia Mondelo‐Macía, Mercedes Salgado, Agueda Iglesias‐Gómez, Laura Codesido, Astrid Irene Díez‐Martín, Joaquín Cubiella, David Posada
João M. Alves, Nuria Estévez‐Gómez, Roberto Piñeiro, Laura Muinelo‐Romay, Patricia Mondelo‐Macía, Mercedes Salgado, Agueda Iglesias‐Gómez, Laura Codesido, Astrid Irene Díez‐Martín, Joaquín Cubiella, David Posada
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.